A Randomized Controlled Trial of Intra-arterial Reperfusion Therapy After Standard Dose Intravenous t-PA Within 4.5 Hours of Stroke Onset Utilizing Dual Target Imaging Selection.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Alteplase
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- Acronyms EXTEND-IA
- 21 Apr 2015 Biomarkers information updated
- 07 Feb 2013 To date, recruitment has started at 7 centres and is planned at another 8, according to a presentation at the 38th International Stroke Conference.
- 07 Feb 2013 Trial design and progress reported at the 38th International Stroke Conference.